Italian Enthera Pharma raise €35m in Series A extension

Enthera Pharmaceuticals extends its €28m Series A financing from last July to a total of €35m as Roche Venture Fund joins the company’s investor syndicate.

Read more

German antibodies in demand in USA

A US subsidiary of Hamburg-based Evotec SE has won a contract from the US government to produce antibodies against SARS-CoV-2.

Read more

Omnix Medical bags €10.8m from EIC Accerator Fund

Israel’s Omnix Medical has been granted €10.8m needed to start Phase I/II development of a potential AMR breaking drug in Gram-negative bugs.

Read more

Germany orders antibody therapies from USA

Germany has become the first country in Europe to buy the US emergency-approved COVID-19 antibody therapies from Regeneron and Eli Lilly.

Read more

Servier and MiNA Therapeutics sign €220m deal

French Servier SA and the UK’s MiNA Therapeutics Ltd have entered into a R&D partnership to identify and develop small activating RNAs (saRNA) to treat neurological disorders.

Read more

LSP leads €21m round into Neurent Medical

Irish life sciences company Neurent Medical has closed a €21m Series B investment co-led by LSP as well as Atlantic Bridge with participation of Fountain Healthcare Partners.

Read more

Janssen presents one-shot COVID-19 vaccine data

J&J subsidiary Janssen Pharma has presented updated Phase I/II antibody levels supporting a single shot administration for its COVID-19 vaccine.

Read more

Valneva in talks with EU about 60 million vaccine doses

French Valneva SE announced it is in advanced discussions with the European Commission (EC) for the supply of up to 60 million doses of its COVID-19 vaccine, VLA2001.

Read more